Year: 2024
MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) is pleased to announce the granting of the Environmental Management Act permits for its 100%-owned Cariboo Gold Project (“Cariboo” or the “Project“) located in central British Columbia (“BC“), Canada. Together with the BC Mines Act permits secured on November 20, 2024, these approvals mark the successful completion of the permitting process for key approvals, solidifying the Cariboo Gold Project’s shovel-ready status.
“We are very pleased with the receipt of the EMA permits, which, together with the Mines Act permits put the Cariboo Gold project in the enviable position of being construction and operation ready. This significant...
Lee Enterprises Reports Fourth Quarter and Full-Year FY24 results
Written by Customer Service on . Posted in Public Companies.
Total Digital Revenue(1) was 51% of revenue in the quarter, representing $82MDigital-only subscription revenue increased 30%(2) in the quarterAmplified Digital® Agency revenue totaled $28M in the quarter, up 21% YOY(2), approaching $100M for the fiscal year
DAVENPORT, Iowa, Dec. 12, 2024 (GLOBE NEWSWIRE) — Lee Enterprises, Incorporated (NASDAQ: LEE), a digital-first subscription platform providing high quality, trusted, local news, information and a major platform for advertising in 73 markets, today reported preliminary fourth quarter fiscal 2024 financial results(3) for the period ended September 29, 2024.
“The team achieved significant milestones in FY24, driving 41% revenue growth(2) in digital subscriptions and approaching $100 million in Amplified Digital® revenue for the fiscal year,” said Kevin Mowbray, Lee’s President...
The Lovesac Company Reports Third Quarter Fiscal 2025 Financial Results
Written by Customer Service on . Posted in Public Companies.
Q3 FY25 Net Sales of $149.9 Million
STAMFORD, Conn., Dec. 12, 2024 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the home furnishing brand best known for its Sactionals, The World’s Most Adaptable Couch, today announced financial results for the third quarter of fiscal 2025, which ended November 3, 2024.
Shawn Nelson, Chief Executive Officer, stated, “Near-term headwinds for our category clearly persisted through the pre-election period. However, we gained market share and strengthened our competitive position through our relentless focus on product innovation and operational excellence. Our expanding portfolio of innovative products is resonating with customers and creating new avenues for sustained growth in the future. The soft launch of our Reclining Seat in the fourth quarter is...
InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025
Written by Customer Service on . Posted in Public Companies.
MIAMI, Dec. 12, 2024 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Craig Shore, Chief Financial Officer, has decided to retire from the Company after a successor CFO is identified and appointed. Mr. Shore will remain as CFO until his successor is appointed and will assist in a smooth and orderly transition.
Marvin Slosman, Chief Executive Officer of InspireMD, commented, “Craig has served the company for 15 years with a tireless commitment to building our business as a global leader in carotid interventions. As we advance our priorities, including potential U.S. FDA approval in the first half of 2025, along with a heightened focus on the investment community, Craig made this decision confident in the future...
Form 8.3 – [LEARNING TECHNOLOGIES GROUP PLC – 11 12 2024] – (CGWL)
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
LEARNING TECHNOLOGIES GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date...
Public Transportation Market Size to Reach USD 652.37 Billion by 2031 | SkyQuest Technology
Written by Customer Service on . Posted in Mergers And Acquisitions.
Westford, USA, Dec. 12, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Public Transportation Market Share will reach a value of USD 652.37 Billion by 2031, with a CAGR of 12.90% during the forecast period (2024-2031). Expansion in the public transportation industry is significantly driven by several reasons, including higher demand for government initiatives aiming to reduce traffic congestion among public. Many governments from across the globe are planning their intentions to increase the locality-based use of public transportation. So, the government through focusing on the deployment of technology, innovative finance, institutional arrangements, and even better experience of the user itself intends to promote more utility of public transport.
Download a detailed overview:
https://www.skyquestt.com/sample-request/public-transportation-market...
Sobi Announces FDA Acceptance of New Drug Application for Avatrombopag (DOPTELET®) for the Treatment of Pediatric Immune Thrombocytopenia
Written by Customer Service on . Posted in Public Companies.
Avatrombopag PDUFA date set for July 24, 2025
WALTHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) — Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®), today announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for avatrombopag (DOPTELET®) for the treatment of thrombocytopenia in pediatric patients one year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to a prior therapy.
The FDA assigned a Prescription Drug User Fee Act (PDUFA) target action date of July 24, 2025.
The FDA also accepted Sobi’s New Drug Application (NDA) for avatrombopag for oral suspension. Avatrombopag for oral suspension is a capsule where its granules are sprinkled onto a soft food or liquid to prepare for...
Form 8.3 – [ECKOH PLC – 11 12 2024] – (CGWL)
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
ECKOH PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date position held/dealing...
Liquidity Services Announces Fourth Quarter Fiscal Year 2024 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Record GMV and Market Share Expansion Cap Year of Innovation and Excellence
BETHESDA, Md., Dec. 12, 2024 (GLOBE NEWSWIRE) — Liquidity Services (NASDAQ:LQDT; www.liquidityservices.com), a leading global commerce company powering the circular economy, today announced its financial results for the quarter ended September 30, 2024, as compared to the corresponding prior year quarter:Gross Merchandise Volume (GMV) of $361.0 million, up 14%, and Revenue of $106.9 million, up 34%
GAAP Net Income of $6.4 million, up $0.1 million, and GAAP Diluted Earnings Per Share (EPS) of $0.20
Non-GAAP Adjusted EBITDA of $14.5 million, up 13%, and Non-GAAP Adjusted EPS of $0.32, up 23%
Cash balances of $155.5 million1 with zero financial debt“Our strong fourth quarter results capped a successful year of market share expansion and consistent...
Form 8.5 (EPT/RI) – Warpaint London Plc
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Name of exempt principal trader:
Shore Capital Stockbrokers Ltd(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
Warpaint London Plc(c) Name of the party to the offer with which exempt principal trader is connected:
Warpaint London Plc(d) Date dealing undertaken:
11 December 2024(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?
Yes – Brand Architekts Group plc2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
(a) Purchases...
